Metabolic & Endocrine Disease Summit (MEDS)
Metabolic & Endocrine Disease Summit (MEDS) Newsletter
International Congress on ATTR Amyloidosis (ICAA)
2nd Annual Going Back to the Heart of Cardiology 2021
Inaugural Medscape Cardiology Newsletter
22nd Annual Las Vegas Dermatology Seminar
Innovations in Dermatology Newsletter
Management of Acute Leukemia for the Community Healthcare Team
Perspectives in Breast Cancer Care
Update in Non-Neoplastic Hematology
Hematologic Malignancies Demystified
Innovations in Psychiatry Newsletter
There are no results under this Specialty.
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
Consider dose escalation and adding an immunomodulator to overcome the impact of antidrug antibodies in rheumatic disease patients.